Absci Corporation (ABSI)
NASDAQ: ABSI · Real-Time Price · USD
2.990
+0.070 (2.40%)
At close: Dec 20, 2024, 4:00 PM
3.183
+0.193 (6.46%)
After-hours: Dec 20, 2024, 6:46 PM EST
Absci Employees
Absci had 155 employees as of December 31, 2023. The number of employees decreased by 38 or -19.69% compared to the previous year.
Employees
155
Change (1Y)
-38
Growth (1Y)
-19.69%
Revenue / Employee
$27,142
Profits / Employee
-$630,116
Market Cap
343.42M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 155 | -38 | -19.69% |
| Dec 31, 2022 | 193 | -19 | -8.96% |
| Dec 31, 2021 | 212 | 110 | 107.84% |
| Dec 31, 2020 | 102 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 676 |
| Revance Therapeutics | 597 |
| Spok Holdings | 384 |
| NeuroPace | 171 |
| Acelyrin | 135 |
| Olema Pharmaceuticals | 74 |
| Jasper Therapeutics | 45 |
| Trevi Therapeutics | 25 |
ABSI News
- 5 weeks ago - Absci Corporation (ABSI) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results - GlobeNewsWire
- 6 weeks ago - Absci to Host R&D Day on December 12, 2024 - GlobeNewsWire
- 2 months ago - Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024 - GlobeNewsWire
- 2 months ago - Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile - Seeking Alpha
- 4 months ago - Absci to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Absci Corporation (ABSI) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results - GlobeNewsWire